Interfascial Pressure Into Ultrasound Guided Anterior Quadratus Lumborum Block Application

Investigation of the Effect of Interfacial Pressure on Block Success During Anterior Quadratus Lumborum Block Application

The block has been shown to be the result of abdominal analgesia as a result of application between the quadratus lumborum (QL) muscle and the leaves in the thoracolumbar fascia.

In this block, local anesthetic drugs are administered between the quadratus lumborum (QL) muscle and the anterior leaf in the thoracolumbar fascia.

In this way, it has been reported that it provides a good analgesia as it relieves somatic pain better in upper and lower abdominal surgeries.

Study Overview

• Status: Completed
• Conditions: Block
• Intervention / Treatment: Device: inter-fascial pressure

Detailed Description

The mechanism of QLB analgesic contains many theories. This study includes the research relationship between the effect of fascial pressure and the success of the association block. We will use the ultrasound guided anterior Quadratus Lumborum Block. A peripheral nerve block catheter will be placed between the quadratus lumborum muscle and the psoas muscle with ultrasound.The pressure between the fascia and the pressure line added to the catheter tip will be measured.A peripheral nerve block catheter will be placed between the quadratus lumborum muscle and the psoas muscle with ultrasound. The pressure between the fascia and the pressure line added to the catheter tip will be measured.

• Study Type: Interventional
• Enrollment (Actual): 72
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Bursa, Turkey
    • University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

Patients who were in the American Society of Anesthesiologists (ASA) I-III class

• Underwent laparoscopic cholecystectomy

Exclusion Criteria:

• Previous history of preoperative opioid use,
• Allergy to local anesthetics,
• The presence of any systemic infection,
• Uncontrolled arterial hypertension,
• Uncontrolled diabetes mellitus
• Presence of infection in the block area,

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Quadratus Lumborum block; We will use the ultrasound guided anterior Quadratus Lumborum Block.A peripheral nerve block catheter will be placed between the quadratus lumborum muscle and the psoas muscle with ultrasound	Device: inter-fascial pressure; The pressure between the fascia and the pressure line added to the catheter tip will be measured.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Interfascial Pressure (mm/hg)	İnterfascial pressure will be measured the postoperative 24. hours through catheter.	24 hours.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Visual Analog Scale	Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)	Postoperative 24 hours
analgesic use	analgesic use	Postoperative 24 hours
sensory block level	After the application, the sensory block level at the 30 minutes after the block application and 30 minutes after the operation will be determined by cold test.	peroperative 3 hours

Collaborators and Investigators

• Sponsor: Bursa Yüksek İhtisas Education and Research Hospital
• Investigators: Principal Investigator: Korgün Ökmen, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): September 29, 2019
• Primary Completion (Actual): October 15, 2019
• Study Completion (Actual): September 15, 2020

Study Registration Dates

• First Submitted: September 11, 2019
• First Submitted That Met QC Criteria: September 17, 2019
• First Posted (Actual): September 19, 2019

Study Record Updates

• Last Update Posted (Actual): February 2, 2021
• Last Update Submitted That Met QC Criteria: February 1, 2021
• Last Verified: February 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: 2011-KAEK-25 2019/05-26

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No